Mexin Medicaments Private Limited
About Mexin Medicaments Private Limited
Data last updated:
Mexin Medicaments Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Kaygee Investments Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the diversified financial services segment of the financial services sector. It was incorporated on 14 January 1980.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH1980PTC022105. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.25 Cr. It was led by directors including Pranay Premchand Godha and Prashant Premchand Godha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at 203A Vastu Prestige New Link Road Andheri (W), Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.67 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹7.15 Lakh (net margin 56.4%) and EBITDA of ₹11.15 Lakh (EBITDA margin 88%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
As per MCA filings, the company had open charges of ₹8.37 Cr on record. Court records list 4 cases involving the company, including 4 filed against it.
Company details
Contact details
Mexin Medicaments Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address203A Vastu Prestige New Link Road Andheri (W), Mumbai, Maharashtra, India – 400053
- IndustryFinancial Services, Diversified Financial Services
To see the full contact details of Mexin Medicaments Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mexin Medicaments Private Limited
FY 2024 filings availableMexin Medicaments Private Limited reported revenue of ₹12.67 Lakh (down 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 88% | ||||
| Net Profit Margin | 56.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mexin Medicaments Private Limited, buy the company report.
Board of directors of Mexin Medicaments Private Limited
Mexin Medicaments has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pranay Premchand Godha Also directs: Ipca Laboratories Limited, Kaygee Laboratories Private Limited, Kaygee Investments Private Limited and 3 more | Director | 07 Sep 2015 | 11 Years 2 Months | As last reported |
| Prashant Premchand Godha Also directs: Ipca Laboratories Limited, Kaygee Laboratories Private Limited, Kaygee Investments Private Limited and 5 more | Director | 07 Sep 2015 | 11 Years 2 Months | As last reported |
| Premchand Gigalal Godha Also directs: Ipca Laboratories Limited, Kaygee Laboratories Private Limited, Kaygee Investments Private Limited and 1 more | Director | 25 Sep 2021 | 5 Years 1 Months | As last reported |
Peer comparison
Mexin Medicaments Private Limited is compared with the 4 companies closest to it by revenue in the BFSI industry (Other Financial Services), with the same principal business activity (other financial activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Silveredge Corporate Services Private Limited | ₹12.68 Lakh (FY 2024) | -88.0% | New Delhi, Delhi, India | |||
| Kakar Assets Advisors Private Limited | ₹12.67 Lakh (FY 2025) | 22.0% | Mumbai, Maharashtra, India | |||
| Mexin Medicaments Private Limitedthis company | ₹12.67 Lakh (FY 2024) | ₹7.15 Lakh | 56.4% | -25.0% | Mumbai, Maharashtra, India | |
| Maloney Investments Private Limited | ₹12.67 Lakh (FY 2025) | 61.0% | Chandigarh, India | |||
| Hanuman Tie-Up Private Limited | ₹12.65 Lakh (FY 2025) | 8.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Mexin Medicaments Private Limited, buy the company report.
Auditor
Mexin Medicaments Private Limited is audited by AGARWAL & MANGAL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL & MANGAL | FY 2023 | 100061W |
Shareholding
The shareholding of Mexin Medicaments Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mexin Medicaments Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 1997 | 90371690 | The Vysya Bank Ltd. | ₹4.25 Cr | Open | |
| 27 Nov 1994 | 90371286 | State Bank of India | ₹1.18 Cr | Open | |
| 09 Aug 1994 | 90377831 | Union Bank of India | ₹49 Lakh | Open | |
| 20 Dec 1991 | 90371285 | State Bank of India | ₹1.18 Cr | Open | |
| 10 Dec 1991 | 90371503 | State Bank of India | ₹8.85 Lakh | Open |
To see the full charge records of Mexin Medicaments Private Limited, buy the company report.
Total charge records: 14 View all charges
Legal cases
Mexin Medicaments Private Limited has 4 court cases on record: 4 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 4 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Tax appeal | Filed against the company by Commissioner of Income Tax | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by Commissioner of Income Tax Central-I, Mumbai | Disposed |
| Bombay High Court | Court case (NMA) | Filed against the company by The Commissioner of Income-Tax, Mumbai Central-Ii. | Disposed |
| Bombay High Court | Court case (NMA) | Filed against the company by The Commissioner of Income-Tax, Mumbai Central II. | Disposed |
To see the full case history of Mexin Medicaments Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mexin Medicaments Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mexin Medicaments has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Mexin Medicaments Private Limited, buy the company report.
Recent activity
Mexin Medicaments Private Limited has 10 board changes on record since 2008: 3 appointments and 7 cessations. The latest: Premchand Gigalal Godha ceased to be Additional Director on 27 Aug 2022.
19 earlier events are in the company report.
Frequently asked questions
Mexin Medicaments has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Mexin Medicaments was a private limited company based in Mumbai, Maharashtra, India. The company worked in diversified financial services, within the financial services industry. It was incorporated on 14 January 1980 and is registered under CIN U24100MH1980PTC022105. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Mexin Medicaments was incorporated on 14 January 1980. It is registered with the Registrar of Companies, Mumbai.
Mexin Medicaments had 3 directors:
- Pranay Premchand Godha - Director
- Prashant Premchand Godha - Director
- Premchand Gigalal Godha - Director
The CIN (Corporate Identification Number) of Mexin Medicaments is U24100MH1980PTC022105. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Mexin Medicaments is at 203A Vastu Prestige New Link Road Andheri W, Mumbai, Maharashtra, India – 400053.
The latest financial statements of Mexin Medicaments on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Mexin Medicaments has 2 GST registrations on record and all of them are cancelled or inactive.
Mexin Medicaments operated in the financial services industry, in the diversified financial services segment.
The peers of Mexin Medicaments by revenue are Silveredge Corporate Services Private Limited, Kakar Assets Advisors Private Limited, Maloney Investments Private Limited, Hanuman Tie-Up Private Limited, all in the BFSI industry (Other Financial Services), with the same principal business activity (other financial activities).
Mexin Medicaments has 4 court cases on record: 4 filed against it.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
